Connect with us

Companies & Markets

Fidson Healthcare posts N5.9 billion pre-tax profit

Published

on

In FY 2023, Fidson Healthcare Plc reported a pre-tax profit of N5.9 billion, a slight 2.4% rise over the N5.8 billion reported in 2022.

The company reported N53.1 billion in revenue for 2023, up 30.6% from N40.6 billion in revenue for 2022, according to its audited financial statement.

Sales of ethical items accounted for almost 61% of the company’s income. Drugs, injectables, and infusions that can only be purchased by customers with a valid prescription are considered ethical products.

Fidson Healthcare which is the most valuable healthcare company listed on the NGX, has quite a large catalogue of drugs it manufactures including anti-infectives, anti-malarial, dermatological medicines, gastrointestinal medicines, and supplements, among others.

Advertisement

Key Highlights (FY 2023 vs FY 2022)

Revenue: N53.1 billion, +30.6% YoY

Cost of sales: N32.0 billion, +36.3% YoY

Gross profit: N21.1 billion, +36.5% YoY

Selling and distribution expenses: N5.5 billion, +13.1% YoY

Advertisement

Operating profit: N8.0 billion, +6.8% YoY

Profit before tax: N5.9 billion, +2.4% YoY

Profit for the year: N3.6 billion, -13.8% YoY

Total assets: N62.0 billion, +44% YoY

Apart from its ethical drugs, its over-the-counter drugs generated about N15.9 billion in revenue, marking a 33.2% increase from the N11.9 billion made in 2022.

Advertisement

In 2023, Fidson Healthcare reported a net exchange loss of N1.3 billion, representing a 66.3% increase from the N760.6 million exchange loss in 2022. As a pharmaceutical business, it is quite impressive how Fidson Healthcare was able to reduce its FX exposures in 2023.

Breaking down the company’s finance cost, it is observable that the interest on bank loans declined to N1.5 billion, from 2022’s N1.6 billion despite rising interest rates during the fiscal year.

However, interest on commercial paper appreciated to N594.1 million, representing an 870.6% increase from the N61.2 billion.

It mirrors the company’s shift towards commercial papers in 2023, as Fidson Healthcare raised about N15 billion through the program last year.

Advertisement
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *